Global mRNA Vaccines and mRNA Drugs Supply, Demand and Key Producers, 2023-2029
The global mRNA Vaccines and mRNA Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global mRNA Vaccines and mRNA Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for mRNA Vaccines and mRNA Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of mRNA Vaccines and mRNA Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global mRNA Vaccines and mRNA Drugs total production and demand, 2018-2029, (K Units)
Global mRNA Vaccines and mRNA Drugs total production value, 2018-2029, (USD Million)
Global mRNA Vaccines and mRNA Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global mRNA Vaccines and mRNA Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: mRNA Vaccines and mRNA Drugs domestic production, consumption, key domestic manufacturers and share
Global mRNA Vaccines and mRNA Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global mRNA Vaccines and mRNA Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global mRNA Vaccines and mRNA Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global mRNA Vaccines and mRNA Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher, Merck, Qiagen N.V., CureVac, In-Cell-Art, eTheRNA, Takara Bio Inc., Sangamo Therapeutics and Roche CustomBiotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World mRNA Vaccines and mRNA Drugs market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global mRNA Vaccines and mRNA Drugs Market, By Region:
1. How big is the global mRNA Vaccines and mRNA Drugs market?
2. What is the demand of the global mRNA Vaccines and mRNA Drugs market?
3. What is the year over year growth of the global mRNA Vaccines and mRNA Drugs market?
4. What is the production and production value of the global mRNA Vaccines and mRNA Drugs market?
5. Who are the key producers in the global mRNA Vaccines and mRNA Drugs market?
This report studies the global mRNA Vaccines and mRNA Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for mRNA Vaccines and mRNA Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of mRNA Vaccines and mRNA Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global mRNA Vaccines and mRNA Drugs total production and demand, 2018-2029, (K Units)
Global mRNA Vaccines and mRNA Drugs total production value, 2018-2029, (USD Million)
Global mRNA Vaccines and mRNA Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global mRNA Vaccines and mRNA Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: mRNA Vaccines and mRNA Drugs domestic production, consumption, key domestic manufacturers and share
Global mRNA Vaccines and mRNA Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global mRNA Vaccines and mRNA Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global mRNA Vaccines and mRNA Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global mRNA Vaccines and mRNA Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher, Merck, Qiagen N.V., CureVac, In-Cell-Art, eTheRNA, Takara Bio Inc., Sangamo Therapeutics and Roche CustomBiotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World mRNA Vaccines and mRNA Drugs market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global mRNA Vaccines and mRNA Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Vaccine
- API
- Infectious Disease
- Cancer
- Thermo Fisher
- Merck
- Qiagen N.V.
- CureVac
- In-Cell-Art
- eTheRNA
- Takara Bio Inc.
- Sangamo Therapeutics
- Roche CustomBiotech
- BioNTech
- Tiba Biotechnology
- TriLink Bio Technologies
- Argos Therapeutics
- Moderna Therapeutics
- NEB
- Ethris
- Aldevron
- Promega
- Translate Bio
1. How big is the global mRNA Vaccines and mRNA Drugs market?
2. What is the demand of the global mRNA Vaccines and mRNA Drugs market?
3. What is the year over year growth of the global mRNA Vaccines and mRNA Drugs market?
4. What is the production and production value of the global mRNA Vaccines and mRNA Drugs market?
5. Who are the key producers in the global mRNA Vaccines and mRNA Drugs market?
1 SUPPLY SUMMARY
1.1 mRNA Vaccines and mRNA Drugs Introduction
1.2 World mRNA Vaccines and mRNA Drugs Supply & Forecast
1.2.1 World mRNA Vaccines and mRNA Drugs Production Value (2018 & 2022 & 2029)
1.2.2 World mRNA Vaccines and mRNA Drugs Production (2018-2029)
1.2.3 World mRNA Vaccines and mRNA Drugs Pricing Trends (2018-2029)
1.3 World mRNA Vaccines and mRNA Drugs Production by Region (Based on Production Site)
1.3.1 World mRNA Vaccines and mRNA Drugs Production Value by Region (2018-2029)
1.3.2 World mRNA Vaccines and mRNA Drugs Production by Region (2018-2029)
1.3.3 World mRNA Vaccines and mRNA Drugs Average Price by Region (2018-2029)
1.3.4 North America mRNA Vaccines and mRNA Drugs Production (2018-2029)
1.3.5 Europe mRNA Vaccines and mRNA Drugs Production (2018-2029)
1.3.6 China mRNA Vaccines and mRNA Drugs Production (2018-2029)
1.3.7 Japan mRNA Vaccines and mRNA Drugs Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 mRNA Vaccines and mRNA Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 mRNA Vaccines and mRNA Drugs Major Market Trends
2 DEMAND SUMMARY
2.1 World mRNA Vaccines and mRNA Drugs Demand (2018-2029)
2.2 World mRNA Vaccines and mRNA Drugs Consumption by Region
2.2.1 World mRNA Vaccines and mRNA Drugs Consumption by Region (2018-2023)
2.2.2 World mRNA Vaccines and mRNA Drugs Consumption Forecast by Region (2024-2029)
2.3 United States mRNA Vaccines and mRNA Drugs Consumption (2018-2029)
2.4 China mRNA Vaccines and mRNA Drugs Consumption (2018-2029)
2.5 Europe mRNA Vaccines and mRNA Drugs Consumption (2018-2029)
2.6 Japan mRNA Vaccines and mRNA Drugs Consumption (2018-2029)
2.7 South Korea mRNA Vaccines and mRNA Drugs Consumption (2018-2029)
2.8 ASEAN mRNA Vaccines and mRNA Drugs Consumption (2018-2029)
2.9 India mRNA Vaccines and mRNA Drugs Consumption (2018-2029)
3 WORLD MRNA VACCINES AND MRNA DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World mRNA Vaccines and mRNA Drugs Production Value by Manufacturer (2018-2023)
3.2 World mRNA Vaccines and mRNA Drugs Production by Manufacturer (2018-2023)
3.3 World mRNA Vaccines and mRNA Drugs Average Price by Manufacturer (2018-2023)
3.4 mRNA Vaccines and mRNA Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global mRNA Vaccines and mRNA Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for mRNA Vaccines and mRNA Drugs in 2022
3.5.3 Global Concentration Ratios (CR8) for mRNA Vaccines and mRNA Drugs in 2022
3.6 mRNA Vaccines and mRNA Drugs Market: Overall Company Footprint Analysis
3.6.1 mRNA Vaccines and mRNA Drugs Market: Region Footprint
3.6.2 mRNA Vaccines and mRNA Drugs Market: Company Product Type Footprint
3.6.3 mRNA Vaccines and mRNA Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: mRNA Vaccines and mRNA Drugs Production Value Comparison
4.1.1 United States VS China: mRNA Vaccines and mRNA Drugs Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: mRNA Vaccines and mRNA Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: mRNA Vaccines and mRNA Drugs Production Comparison
4.2.1 United States VS China: mRNA Vaccines and mRNA Drugs Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: mRNA Vaccines and mRNA Drugs Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: mRNA Vaccines and mRNA Drugs Consumption Comparison
4.3.1 United States VS China: mRNA Vaccines and mRNA Drugs Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: mRNA Vaccines and mRNA Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based mRNA Vaccines and mRNA Drugs Manufacturers and Market Share, 2018-2023
4.4.1 United States Based mRNA Vaccines and mRNA Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers mRNA Vaccines and mRNA Drugs Production Value (2018-2023)
4.4.3 United States Based Manufacturers mRNA Vaccines and mRNA Drugs Production (2018-2023)
4.5 China Based mRNA Vaccines and mRNA Drugs Manufacturers and Market Share
4.5.1 China Based mRNA Vaccines and mRNA Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers mRNA Vaccines and mRNA Drugs Production Value (2018-2023)
4.5.3 China Based Manufacturers mRNA Vaccines and mRNA Drugs Production (2018-2023)
4.6 Rest of World Based mRNA Vaccines and mRNA Drugs Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based mRNA Vaccines and mRNA Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers mRNA Vaccines and mRNA Drugs Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers mRNA Vaccines and mRNA Drugs Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World mRNA Vaccines and mRNA Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Vaccine
5.2.2 API
5.3 Market Segment by Type
5.3.1 World mRNA Vaccines and mRNA Drugs Production by Type (2018-2029)
5.3.2 World mRNA Vaccines and mRNA Drugs Production Value by Type (2018-2029)
5.3.3 World mRNA Vaccines and mRNA Drugs Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World mRNA Vaccines and mRNA Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Infectious Disease
6.2.2 Cancer
6.3 Market Segment by Application
6.3.1 World mRNA Vaccines and mRNA Drugs Production by Application (2018-2029)
6.3.2 World mRNA Vaccines and mRNA Drugs Production Value by Application (2018-2029)
6.3.3 World mRNA Vaccines and mRNA Drugs Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Thermo Fisher
7.1.1 Thermo Fisher Details
7.1.2 Thermo Fisher Major Business
7.1.3 Thermo Fisher mRNA Vaccines and mRNA Drugs Product and Services
7.1.4 Thermo Fisher mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Thermo Fisher Recent Developments/Updates
7.1.6 Thermo Fisher Competitive Strengths & Weaknesses
7.2 Merck
7.2.1 Merck Details
7.2.2 Merck Major Business
7.2.3 Merck mRNA Vaccines and mRNA Drugs Product and Services
7.2.4 Merck mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Merck Recent Developments/Updates
7.2.6 Merck Competitive Strengths & Weaknesses
7.3 Qiagen N.V.
7.3.1 Qiagen N.V. Details
7.3.2 Qiagen N.V. Major Business
7.3.3 Qiagen N.V. mRNA Vaccines and mRNA Drugs Product and Services
7.3.4 Qiagen N.V. mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Qiagen N.V. Recent Developments/Updates
7.3.6 Qiagen N.V. Competitive Strengths & Weaknesses
7.4 CureVac
7.4.1 CureVac Details
7.4.2 CureVac Major Business
7.4.3 CureVac mRNA Vaccines and mRNA Drugs Product and Services
7.4.4 CureVac mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 CureVac Recent Developments/Updates
7.4.6 CureVac Competitive Strengths & Weaknesses
7.5 In-Cell-Art
7.5.1 In-Cell-Art Details
7.5.2 In-Cell-Art Major Business
7.5.3 In-Cell-Art mRNA Vaccines and mRNA Drugs Product and Services
7.5.4 In-Cell-Art mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 In-Cell-Art Recent Developments/Updates
7.5.6 In-Cell-Art Competitive Strengths & Weaknesses
7.6 eTheRNA
7.6.1 eTheRNA Details
7.6.2 eTheRNA Major Business
7.6.3 eTheRNA mRNA Vaccines and mRNA Drugs Product and Services
7.6.4 eTheRNA mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 eTheRNA Recent Developments/Updates
7.6.6 eTheRNA Competitive Strengths & Weaknesses
7.7 Takara Bio Inc.
7.7.1 Takara Bio Inc. Details
7.7.2 Takara Bio Inc. Major Business
7.7.3 Takara Bio Inc. mRNA Vaccines and mRNA Drugs Product and Services
7.7.4 Takara Bio Inc. mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Takara Bio Inc. Recent Developments/Updates
7.7.6 Takara Bio Inc. Competitive Strengths & Weaknesses
7.8 Sangamo Therapeutics
7.8.1 Sangamo Therapeutics Details
7.8.2 Sangamo Therapeutics Major Business
7.8.3 Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Product and Services
7.8.4 Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Sangamo Therapeutics Recent Developments/Updates
7.8.6 Sangamo Therapeutics Competitive Strengths & Weaknesses
7.9 Roche CustomBiotech
7.9.1 Roche CustomBiotech Details
7.9.2 Roche CustomBiotech Major Business
7.9.3 Roche CustomBiotech mRNA Vaccines and mRNA Drugs Product and Services
7.9.4 Roche CustomBiotech mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Roche CustomBiotech Recent Developments/Updates
7.9.6 Roche CustomBiotech Competitive Strengths & Weaknesses
7.10 BioNTech
7.10.1 BioNTech Details
7.10.2 BioNTech Major Business
7.10.3 BioNTech mRNA Vaccines and mRNA Drugs Product and Services
7.10.4 BioNTech mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 BioNTech Recent Developments/Updates
7.10.6 BioNTech Competitive Strengths & Weaknesses
7.11 Tiba Biotechnology
7.11.1 Tiba Biotechnology Details
7.11.2 Tiba Biotechnology Major Business
7.11.3 Tiba Biotechnology mRNA Vaccines and mRNA Drugs Product and Services
7.11.4 Tiba Biotechnology mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Tiba Biotechnology Recent Developments/Updates
7.11.6 Tiba Biotechnology Competitive Strengths & Weaknesses
7.12 TriLink Bio Technologies
7.12.1 TriLink Bio Technologies Details
7.12.2 TriLink Bio Technologies Major Business
7.12.3 TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Product and Services
7.12.4 TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 TriLink Bio Technologies Recent Developments/Updates
7.12.6 TriLink Bio Technologies Competitive Strengths & Weaknesses
7.13 Argos Therapeutics
7.13.1 Argos Therapeutics Details
7.13.2 Argos Therapeutics Major Business
7.13.3 Argos Therapeutics mRNA Vaccines and mRNA Drugs Product and Services
7.13.4 Argos Therapeutics mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Argos Therapeutics Recent Developments/Updates
7.13.6 Argos Therapeutics Competitive Strengths & Weaknesses
7.14 Moderna Therapeutics
7.14.1 Moderna Therapeutics Details
7.14.2 Moderna Therapeutics Major Business
7.14.3 Moderna Therapeutics mRNA Vaccines and mRNA Drugs Product and Services
7.14.4 Moderna Therapeutics mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Moderna Therapeutics Recent Developments/Updates
7.14.6 Moderna Therapeutics Competitive Strengths & Weaknesses
7.15 NEB
7.15.1 NEB Details
7.15.2 NEB Major Business
7.15.3 NEB mRNA Vaccines and mRNA Drugs Product and Services
7.15.4 NEB mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 NEB Recent Developments/Updates
7.15.6 NEB Competitive Strengths & Weaknesses
7.16 Ethris
7.16.1 Ethris Details
7.16.2 Ethris Major Business
7.16.3 Ethris mRNA Vaccines and mRNA Drugs Product and Services
7.16.4 Ethris mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Ethris Recent Developments/Updates
7.16.6 Ethris Competitive Strengths & Weaknesses
7.17 Aldevron
7.17.1 Aldevron Details
7.17.2 Aldevron Major Business
7.17.3 Aldevron mRNA Vaccines and mRNA Drugs Product and Services
7.17.4 Aldevron mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Aldevron Recent Developments/Updates
7.17.6 Aldevron Competitive Strengths & Weaknesses
7.18 Promega
7.18.1 Promega Details
7.18.2 Promega Major Business
7.18.3 Promega mRNA Vaccines and mRNA Drugs Product and Services
7.18.4 Promega mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Promega Recent Developments/Updates
7.18.6 Promega Competitive Strengths & Weaknesses
7.19 Translate Bio
7.19.1 Translate Bio Details
7.19.2 Translate Bio Major Business
7.19.3 Translate Bio mRNA Vaccines and mRNA Drugs Product and Services
7.19.4 Translate Bio mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Translate Bio Recent Developments/Updates
7.19.6 Translate Bio Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 mRNA Vaccines and mRNA Drugs Industry Chain
8.2 mRNA Vaccines and mRNA Drugs Upstream Analysis
8.2.1 mRNA Vaccines and mRNA Drugs Core Raw Materials
8.2.2 Main Manufacturers of mRNA Vaccines and mRNA Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 mRNA Vaccines and mRNA Drugs Production Mode
8.6 mRNA Vaccines and mRNA Drugs Procurement Model
8.7 mRNA Vaccines and mRNA Drugs Industry Sales Model and Sales Channels
8.7.1 mRNA Vaccines and mRNA Drugs Sales Model
8.7.2 mRNA Vaccines and mRNA Drugs Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 mRNA Vaccines and mRNA Drugs Introduction
1.2 World mRNA Vaccines and mRNA Drugs Supply & Forecast
1.2.1 World mRNA Vaccines and mRNA Drugs Production Value (2018 & 2022 & 2029)
1.2.2 World mRNA Vaccines and mRNA Drugs Production (2018-2029)
1.2.3 World mRNA Vaccines and mRNA Drugs Pricing Trends (2018-2029)
1.3 World mRNA Vaccines and mRNA Drugs Production by Region (Based on Production Site)
1.3.1 World mRNA Vaccines and mRNA Drugs Production Value by Region (2018-2029)
1.3.2 World mRNA Vaccines and mRNA Drugs Production by Region (2018-2029)
1.3.3 World mRNA Vaccines and mRNA Drugs Average Price by Region (2018-2029)
1.3.4 North America mRNA Vaccines and mRNA Drugs Production (2018-2029)
1.3.5 Europe mRNA Vaccines and mRNA Drugs Production (2018-2029)
1.3.6 China mRNA Vaccines and mRNA Drugs Production (2018-2029)
1.3.7 Japan mRNA Vaccines and mRNA Drugs Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 mRNA Vaccines and mRNA Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 mRNA Vaccines and mRNA Drugs Major Market Trends
2 DEMAND SUMMARY
2.1 World mRNA Vaccines and mRNA Drugs Demand (2018-2029)
2.2 World mRNA Vaccines and mRNA Drugs Consumption by Region
2.2.1 World mRNA Vaccines and mRNA Drugs Consumption by Region (2018-2023)
2.2.2 World mRNA Vaccines and mRNA Drugs Consumption Forecast by Region (2024-2029)
2.3 United States mRNA Vaccines and mRNA Drugs Consumption (2018-2029)
2.4 China mRNA Vaccines and mRNA Drugs Consumption (2018-2029)
2.5 Europe mRNA Vaccines and mRNA Drugs Consumption (2018-2029)
2.6 Japan mRNA Vaccines and mRNA Drugs Consumption (2018-2029)
2.7 South Korea mRNA Vaccines and mRNA Drugs Consumption (2018-2029)
2.8 ASEAN mRNA Vaccines and mRNA Drugs Consumption (2018-2029)
2.9 India mRNA Vaccines and mRNA Drugs Consumption (2018-2029)
3 WORLD MRNA VACCINES AND MRNA DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World mRNA Vaccines and mRNA Drugs Production Value by Manufacturer (2018-2023)
3.2 World mRNA Vaccines and mRNA Drugs Production by Manufacturer (2018-2023)
3.3 World mRNA Vaccines and mRNA Drugs Average Price by Manufacturer (2018-2023)
3.4 mRNA Vaccines and mRNA Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global mRNA Vaccines and mRNA Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for mRNA Vaccines and mRNA Drugs in 2022
3.5.3 Global Concentration Ratios (CR8) for mRNA Vaccines and mRNA Drugs in 2022
3.6 mRNA Vaccines and mRNA Drugs Market: Overall Company Footprint Analysis
3.6.1 mRNA Vaccines and mRNA Drugs Market: Region Footprint
3.6.2 mRNA Vaccines and mRNA Drugs Market: Company Product Type Footprint
3.6.3 mRNA Vaccines and mRNA Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: mRNA Vaccines and mRNA Drugs Production Value Comparison
4.1.1 United States VS China: mRNA Vaccines and mRNA Drugs Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: mRNA Vaccines and mRNA Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: mRNA Vaccines and mRNA Drugs Production Comparison
4.2.1 United States VS China: mRNA Vaccines and mRNA Drugs Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: mRNA Vaccines and mRNA Drugs Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: mRNA Vaccines and mRNA Drugs Consumption Comparison
4.3.1 United States VS China: mRNA Vaccines and mRNA Drugs Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: mRNA Vaccines and mRNA Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based mRNA Vaccines and mRNA Drugs Manufacturers and Market Share, 2018-2023
4.4.1 United States Based mRNA Vaccines and mRNA Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers mRNA Vaccines and mRNA Drugs Production Value (2018-2023)
4.4.3 United States Based Manufacturers mRNA Vaccines and mRNA Drugs Production (2018-2023)
4.5 China Based mRNA Vaccines and mRNA Drugs Manufacturers and Market Share
4.5.1 China Based mRNA Vaccines and mRNA Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers mRNA Vaccines and mRNA Drugs Production Value (2018-2023)
4.5.3 China Based Manufacturers mRNA Vaccines and mRNA Drugs Production (2018-2023)
4.6 Rest of World Based mRNA Vaccines and mRNA Drugs Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based mRNA Vaccines and mRNA Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers mRNA Vaccines and mRNA Drugs Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers mRNA Vaccines and mRNA Drugs Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World mRNA Vaccines and mRNA Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Vaccine
5.2.2 API
5.3 Market Segment by Type
5.3.1 World mRNA Vaccines and mRNA Drugs Production by Type (2018-2029)
5.3.2 World mRNA Vaccines and mRNA Drugs Production Value by Type (2018-2029)
5.3.3 World mRNA Vaccines and mRNA Drugs Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World mRNA Vaccines and mRNA Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Infectious Disease
6.2.2 Cancer
6.3 Market Segment by Application
6.3.1 World mRNA Vaccines and mRNA Drugs Production by Application (2018-2029)
6.3.2 World mRNA Vaccines and mRNA Drugs Production Value by Application (2018-2029)
6.3.3 World mRNA Vaccines and mRNA Drugs Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Thermo Fisher
7.1.1 Thermo Fisher Details
7.1.2 Thermo Fisher Major Business
7.1.3 Thermo Fisher mRNA Vaccines and mRNA Drugs Product and Services
7.1.4 Thermo Fisher mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Thermo Fisher Recent Developments/Updates
7.1.6 Thermo Fisher Competitive Strengths & Weaknesses
7.2 Merck
7.2.1 Merck Details
7.2.2 Merck Major Business
7.2.3 Merck mRNA Vaccines and mRNA Drugs Product and Services
7.2.4 Merck mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Merck Recent Developments/Updates
7.2.6 Merck Competitive Strengths & Weaknesses
7.3 Qiagen N.V.
7.3.1 Qiagen N.V. Details
7.3.2 Qiagen N.V. Major Business
7.3.3 Qiagen N.V. mRNA Vaccines and mRNA Drugs Product and Services
7.3.4 Qiagen N.V. mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Qiagen N.V. Recent Developments/Updates
7.3.6 Qiagen N.V. Competitive Strengths & Weaknesses
7.4 CureVac
7.4.1 CureVac Details
7.4.2 CureVac Major Business
7.4.3 CureVac mRNA Vaccines and mRNA Drugs Product and Services
7.4.4 CureVac mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 CureVac Recent Developments/Updates
7.4.6 CureVac Competitive Strengths & Weaknesses
7.5 In-Cell-Art
7.5.1 In-Cell-Art Details
7.5.2 In-Cell-Art Major Business
7.5.3 In-Cell-Art mRNA Vaccines and mRNA Drugs Product and Services
7.5.4 In-Cell-Art mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 In-Cell-Art Recent Developments/Updates
7.5.6 In-Cell-Art Competitive Strengths & Weaknesses
7.6 eTheRNA
7.6.1 eTheRNA Details
7.6.2 eTheRNA Major Business
7.6.3 eTheRNA mRNA Vaccines and mRNA Drugs Product and Services
7.6.4 eTheRNA mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 eTheRNA Recent Developments/Updates
7.6.6 eTheRNA Competitive Strengths & Weaknesses
7.7 Takara Bio Inc.
7.7.1 Takara Bio Inc. Details
7.7.2 Takara Bio Inc. Major Business
7.7.3 Takara Bio Inc. mRNA Vaccines and mRNA Drugs Product and Services
7.7.4 Takara Bio Inc. mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Takara Bio Inc. Recent Developments/Updates
7.7.6 Takara Bio Inc. Competitive Strengths & Weaknesses
7.8 Sangamo Therapeutics
7.8.1 Sangamo Therapeutics Details
7.8.2 Sangamo Therapeutics Major Business
7.8.3 Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Product and Services
7.8.4 Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Sangamo Therapeutics Recent Developments/Updates
7.8.6 Sangamo Therapeutics Competitive Strengths & Weaknesses
7.9 Roche CustomBiotech
7.9.1 Roche CustomBiotech Details
7.9.2 Roche CustomBiotech Major Business
7.9.3 Roche CustomBiotech mRNA Vaccines and mRNA Drugs Product and Services
7.9.4 Roche CustomBiotech mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Roche CustomBiotech Recent Developments/Updates
7.9.6 Roche CustomBiotech Competitive Strengths & Weaknesses
7.10 BioNTech
7.10.1 BioNTech Details
7.10.2 BioNTech Major Business
7.10.3 BioNTech mRNA Vaccines and mRNA Drugs Product and Services
7.10.4 BioNTech mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 BioNTech Recent Developments/Updates
7.10.6 BioNTech Competitive Strengths & Weaknesses
7.11 Tiba Biotechnology
7.11.1 Tiba Biotechnology Details
7.11.2 Tiba Biotechnology Major Business
7.11.3 Tiba Biotechnology mRNA Vaccines and mRNA Drugs Product and Services
7.11.4 Tiba Biotechnology mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Tiba Biotechnology Recent Developments/Updates
7.11.6 Tiba Biotechnology Competitive Strengths & Weaknesses
7.12 TriLink Bio Technologies
7.12.1 TriLink Bio Technologies Details
7.12.2 TriLink Bio Technologies Major Business
7.12.3 TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Product and Services
7.12.4 TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 TriLink Bio Technologies Recent Developments/Updates
7.12.6 TriLink Bio Technologies Competitive Strengths & Weaknesses
7.13 Argos Therapeutics
7.13.1 Argos Therapeutics Details
7.13.2 Argos Therapeutics Major Business
7.13.3 Argos Therapeutics mRNA Vaccines and mRNA Drugs Product and Services
7.13.4 Argos Therapeutics mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Argos Therapeutics Recent Developments/Updates
7.13.6 Argos Therapeutics Competitive Strengths & Weaknesses
7.14 Moderna Therapeutics
7.14.1 Moderna Therapeutics Details
7.14.2 Moderna Therapeutics Major Business
7.14.3 Moderna Therapeutics mRNA Vaccines and mRNA Drugs Product and Services
7.14.4 Moderna Therapeutics mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Moderna Therapeutics Recent Developments/Updates
7.14.6 Moderna Therapeutics Competitive Strengths & Weaknesses
7.15 NEB
7.15.1 NEB Details
7.15.2 NEB Major Business
7.15.3 NEB mRNA Vaccines and mRNA Drugs Product and Services
7.15.4 NEB mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 NEB Recent Developments/Updates
7.15.6 NEB Competitive Strengths & Weaknesses
7.16 Ethris
7.16.1 Ethris Details
7.16.2 Ethris Major Business
7.16.3 Ethris mRNA Vaccines and mRNA Drugs Product and Services
7.16.4 Ethris mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Ethris Recent Developments/Updates
7.16.6 Ethris Competitive Strengths & Weaknesses
7.17 Aldevron
7.17.1 Aldevron Details
7.17.2 Aldevron Major Business
7.17.3 Aldevron mRNA Vaccines and mRNA Drugs Product and Services
7.17.4 Aldevron mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Aldevron Recent Developments/Updates
7.17.6 Aldevron Competitive Strengths & Weaknesses
7.18 Promega
7.18.1 Promega Details
7.18.2 Promega Major Business
7.18.3 Promega mRNA Vaccines and mRNA Drugs Product and Services
7.18.4 Promega mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Promega Recent Developments/Updates
7.18.6 Promega Competitive Strengths & Weaknesses
7.19 Translate Bio
7.19.1 Translate Bio Details
7.19.2 Translate Bio Major Business
7.19.3 Translate Bio mRNA Vaccines and mRNA Drugs Product and Services
7.19.4 Translate Bio mRNA Vaccines and mRNA Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Translate Bio Recent Developments/Updates
7.19.6 Translate Bio Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 mRNA Vaccines and mRNA Drugs Industry Chain
8.2 mRNA Vaccines and mRNA Drugs Upstream Analysis
8.2.1 mRNA Vaccines and mRNA Drugs Core Raw Materials
8.2.2 Main Manufacturers of mRNA Vaccines and mRNA Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 mRNA Vaccines and mRNA Drugs Production Mode
8.6 mRNA Vaccines and mRNA Drugs Procurement Model
8.7 mRNA Vaccines and mRNA Drugs Industry Sales Model and Sales Channels
8.7.1 mRNA Vaccines and mRNA Drugs Sales Model
8.7.2 mRNA Vaccines and mRNA Drugs Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World mRNA Vaccines and mRNA Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World mRNA Vaccines and mRNA Drugs Production Value by Region (2018-2023) & (USD Million)
Table 3. World mRNA Vaccines and mRNA Drugs Production Value by Region (2024-2029) & (USD Million)
Table 4. World mRNA Vaccines and mRNA Drugs Production Value Market Share by Region (2018-2023)
Table 5. World mRNA Vaccines and mRNA Drugs Production Value Market Share by Region (2024-2029)
Table 6. World mRNA Vaccines and mRNA Drugs Production by Region (2018-2023) & (K Units)
Table 7. World mRNA Vaccines and mRNA Drugs Production by Region (2024-2029) & (K Units)
Table 8. World mRNA Vaccines and mRNA Drugs Production Market Share by Region (2018-2023)
Table 9. World mRNA Vaccines and mRNA Drugs Production Market Share by Region (2024-2029)
Table 10. World mRNA Vaccines and mRNA Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World mRNA Vaccines and mRNA Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 12. mRNA Vaccines and mRNA Drugs Major Market Trends
Table 13. World mRNA Vaccines and mRNA Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World mRNA Vaccines and mRNA Drugs Consumption by Region (2018-2023) & (K Units)
Table 15. World mRNA Vaccines and mRNA Drugs Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World mRNA Vaccines and mRNA Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key mRNA Vaccines and mRNA Drugs Producers in 2022
Table 18. World mRNA Vaccines and mRNA Drugs Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key mRNA Vaccines and mRNA Drugs Producers in 2022
Table 20. World mRNA Vaccines and mRNA Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global mRNA Vaccines and mRNA Drugs Company Evaluation Quadrant
Table 22. World mRNA Vaccines and mRNA Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and mRNA Vaccines and mRNA Drugs Production Site of Key Manufacturer
Table 24. mRNA Vaccines and mRNA Drugs Market: Company Product Type Footprint
Table 25. mRNA Vaccines and mRNA Drugs Market: Company Product Application Footprint
Table 26. mRNA Vaccines and mRNA Drugs Competitive Factors
Table 27. mRNA Vaccines and mRNA Drugs New Entrant and Capacity Expansion Plans
Table 28. mRNA Vaccines and mRNA Drugs Mergers & Acquisitions Activity
Table 29. United States VS China mRNA Vaccines and mRNA Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China mRNA Vaccines and mRNA Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China mRNA Vaccines and mRNA Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based mRNA Vaccines and mRNA Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers mRNA Vaccines and mRNA Drugs Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers mRNA Vaccines and mRNA Drugs Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers mRNA Vaccines and mRNA Drugs Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers mRNA Vaccines and mRNA Drugs Production Market Share (2018-2023)
Table 37. China Based mRNA Vaccines and mRNA Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers mRNA Vaccines and mRNA Drugs Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers mRNA Vaccines and mRNA Drugs Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers mRNA Vaccines and mRNA Drugs Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers mRNA Vaccines and mRNA Drugs Production Market Share (2018-2023)
Table 42. Rest of World Based mRNA Vaccines and mRNA Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers mRNA Vaccines and mRNA Drugs Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers mRNA Vaccines and mRNA Drugs Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers mRNA Vaccines and mRNA Drugs Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers mRNA Vaccines and mRNA Drugs Production Market Share (2018-2023)
Table 47. World mRNA Vaccines and mRNA Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World mRNA Vaccines and mRNA Drugs Production by Type (2018-2023) & (K Units)
Table 49. World mRNA Vaccines and mRNA Drugs Production by Type (2024-2029) & (K Units)
Table 50. World mRNA Vaccines and mRNA Drugs Production Value by Type (2018-2023) & (USD Million)
Table 51. World mRNA Vaccines and mRNA Drugs Production Value by Type (2024-2029) & (USD Million)
Table 52. World mRNA Vaccines and mRNA Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World mRNA Vaccines and mRNA Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World mRNA Vaccines and mRNA Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World mRNA Vaccines and mRNA Drugs Production by Application (2018-2023) & (K Units)
Table 56. World mRNA Vaccines and mRNA Drugs Production by Application (2024-2029) & (K Units)
Table 57. World mRNA Vaccines and mRNA Drugs Production Value by Application (2018-2023) & (USD Million)
Table 58. World mRNA Vaccines and mRNA Drugs Production Value by Application (2024-2029) & (USD Million)
Table 59. World mRNA Vaccines and mRNA Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World mRNA Vaccines and mRNA Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table 62. Thermo Fisher Major Business
Table 63. Thermo Fisher mRNA Vaccines and mRNA Drugs Product and Services
Table 64. Thermo Fisher mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Thermo Fisher Recent Developments/Updates
Table 66. Thermo Fisher Competitive Strengths & Weaknesses
Table 67. Merck Basic Information, Manufacturing Base and Competitors
Table 68. Merck Major Business
Table 69. Merck mRNA Vaccines and mRNA Drugs Product and Services
Table 70. Merck mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Merck Recent Developments/Updates
Table 72. Merck Competitive Strengths & Weaknesses
Table 73. Qiagen N.V. Basic Information, Manufacturing Base and Competitors
Table 74. Qiagen N.V. Major Business
Table 75. Qiagen N.V. mRNA Vaccines and mRNA Drugs Product and Services
Table 76. Qiagen N.V. mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Qiagen N.V. Recent Developments/Updates
Table 78. Qiagen N.V. Competitive Strengths & Weaknesses
Table 79. CureVac Basic Information, Manufacturing Base and Competitors
Table 80. CureVac Major Business
Table 81. CureVac mRNA Vaccines and mRNA Drugs Product and Services
Table 82. CureVac mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. CureVac Recent Developments/Updates
Table 84. CureVac Competitive Strengths & Weaknesses
Table 85. In-Cell-Art Basic Information, Manufacturing Base and Competitors
Table 86. In-Cell-Art Major Business
Table 87. In-Cell-Art mRNA Vaccines and mRNA Drugs Product and Services
Table 88. In-Cell-Art mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. In-Cell-Art Recent Developments/Updates
Table 90. In-Cell-Art Competitive Strengths & Weaknesses
Table 91. eTheRNA Basic Information, Manufacturing Base and Competitors
Table 92. eTheRNA Major Business
Table 93. eTheRNA mRNA Vaccines and mRNA Drugs Product and Services
Table 94. eTheRNA mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. eTheRNA Recent Developments/Updates
Table 96. eTheRNA Competitive Strengths & Weaknesses
Table 97. Takara Bio Inc. Basic Information, Manufacturing Base and Competitors
Table 98. Takara Bio Inc. Major Business
Table 99. Takara Bio Inc. mRNA Vaccines and mRNA Drugs Product and Services
Table 100. Takara Bio Inc. mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Takara Bio Inc. Recent Developments/Updates
Table 102. Takara Bio Inc. Competitive Strengths & Weaknesses
Table 103. Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors
Table 104. Sangamo Therapeutics Major Business
Table 105. Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Product and Services
Table 106. Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Sangamo Therapeutics Recent Developments/Updates
Table 108. Sangamo Therapeutics Competitive Strengths & Weaknesses
Table 109. Roche CustomBiotech Basic Information, Manufacturing Base and Competitors
Table 110. Roche CustomBiotech Major Business
Table 111. Roche CustomBiotech mRNA Vaccines and mRNA Drugs Product and Services
Table 112. Roche CustomBiotech mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Roche CustomBiotech Recent Developments/Updates
Table 114. Roche CustomBiotech Competitive Strengths & Weaknesses
Table 115. BioNTech Basic Information, Manufacturing Base and Competitors
Table 116. BioNTech Major Business
Table 117. BioNTech mRNA Vaccines and mRNA Drugs Product and Services
Table 118. BioNTech mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. BioNTech Recent Developments/Updates
Table 120. BioNTech Competitive Strengths & Weaknesses
Table 121. Tiba Biotechnology Basic Information, Manufacturing Base and Competitors
Table 122. Tiba Biotechnology Major Business
Table 123. Tiba Biotechnology mRNA Vaccines and mRNA Drugs Product and Services
Table 124. Tiba Biotechnology mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Tiba Biotechnology Recent Developments/Updates
Table 126. Tiba Biotechnology Competitive Strengths & Weaknesses
Table 127. TriLink Bio Technologies Basic Information, Manufacturing Base and Competitors
Table 128. TriLink Bio Technologies Major Business
Table 129. TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Product and Services
Table 130. TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. TriLink Bio Technologies Recent Developments/Updates
Table 132. TriLink Bio Technologies Competitive Strengths & Weaknesses
Table 133. Argos Therapeutics Basic Information, Manufacturing Base and Competitors
Table 134. Argos Therapeutics Major Business
Table 135. Argos Therapeutics mRNA Vaccines and mRNA Drugs Product and Services
Table 136. Argos Therapeutics mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Argos Therapeutics Recent Developments/Updates
Table 138. Argos Therapeutics Competitive Strengths & Weaknesses
Table 139. Moderna Therapeutics Basic Information, Manufacturing Base and Competitors
Table 140. Moderna Therapeutics Major Business
Table 141. Moderna Therapeutics mRNA Vaccines and mRNA Drugs Product and Services
Table 142. Moderna Therapeutics mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Moderna Therapeutics Recent Developments/Updates
Table 144. Moderna Therapeutics Competitive Strengths & Weaknesses
Table 145. NEB Basic Information, Manufacturing Base and Competitors
Table 146. NEB Major Business
Table 147. NEB mRNA Vaccines and mRNA Drugs Product and Services
Table 148. NEB mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. NEB Recent Developments/Updates
Table 150. NEB Competitive Strengths & Weaknesses
Table 151. Ethris Basic Information, Manufacturing Base and Competitors
Table 152. Ethris Major Business
Table 153. Ethris mRNA Vaccines and mRNA Drugs Product and Services
Table 154. Ethris mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Ethris Recent Developments/Updates
Table 156. Ethris Competitive Strengths & Weaknesses
Table 157. Aldevron Basic Information, Manufacturing Base and Competitors
Table 158. Aldevron Major Business
Table 159. Aldevron mRNA Vaccines and mRNA Drugs Product and Services
Table 160. Aldevron mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Aldevron Recent Developments/Updates
Table 162. Aldevron Competitive Strengths & Weaknesses
Table 163. Promega Basic Information, Manufacturing Base and Competitors
Table 164. Promega Major Business
Table 165. Promega mRNA Vaccines and mRNA Drugs Product and Services
Table 166. Promega mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Promega Recent Developments/Updates
Table 168. Translate Bio Basic Information, Manufacturing Base and Competitors
Table 169. Translate Bio Major Business
Table 170. Translate Bio mRNA Vaccines and mRNA Drugs Product and Services
Table 171. Translate Bio mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 172. Global Key Players of mRNA Vaccines and mRNA Drugs Upstream (Raw Materials)
Table 173. mRNA Vaccines and mRNA Drugs Typical Customers
Table 174. mRNA Vaccines and mRNA Drugs Typical Distributors
List of Figure
Figure 1. mRNA Vaccines and mRNA Drugs Picture
Figure 2. World mRNA Vaccines and mRNA Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World mRNA Vaccines and mRNA Drugs Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World mRNA Vaccines and mRNA Drugs Production (2018-2029) & (K Units)
Figure 5. World mRNA Vaccines and mRNA Drugs Average Price (2018-2029) & (US$/Unit)
Figure 6. World mRNA Vaccines and mRNA Drugs Production Value Market Share by Region (2018-2029)
Figure 7. World mRNA Vaccines and mRNA Drugs Production Market Share by Region (2018-2029)
Figure 8. North America mRNA Vaccines and mRNA Drugs Production (2018-2029) & (K Units)
Figure 9. Europe mRNA Vaccines and mRNA Drugs Production (2018-2029) & (K Units)
Figure 10. China mRNA Vaccines and mRNA Drugs Production (2018-2029) & (K Units)
Figure 11. Japan mRNA Vaccines and mRNA Drugs Production (2018-2029) & (K Units)
Figure 12. mRNA Vaccines and mRNA Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World mRNA Vaccines and mRNA Drugs Consumption (2018-2029) & (K Units)
Figure 15. World mRNA Vaccines and mRNA Drugs Consumption Market Share by Region (2018-2029)
Figure 16. United States mRNA Vaccines and mRNA Drugs Consumption (2018-2029) & (K Units)
Figure 17. China mRNA Vaccines and mRNA Drugs Consumption (2018-2029) & (K Units)
Figure 18. Europe mRNA Vaccines and mRNA Drugs Consumption (2018-2029) & (K Units)
Figure 19. Japan mRNA Vaccines and mRNA Drugs Consumption (2018-2029) & (K Units)
Figure 20. South Korea mRNA Vaccines and mRNA Drugs Consumption (2018-2029) & (K Units)
Figure 21. ASEAN mRNA Vaccines and mRNA Drugs Consumption (2018-2029) & (K Units)
Figure 22. India mRNA Vaccines and mRNA Drugs Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of mRNA Vaccines and mRNA Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for mRNA Vaccines and mRNA Drugs Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for mRNA Vaccines and mRNA Drugs Markets in 2022
Figure 26. United States VS China: mRNA Vaccines and mRNA Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: mRNA Vaccines and mRNA Drugs Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: mRNA Vaccines and mRNA Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers mRNA Vaccines and mRNA Drugs Production Market Share 2022
Figure 30. China Based Manufacturers mRNA Vaccines and mRNA Drugs Production Market Share 2022
Figure 31. Rest of World Based Manufacturers mRNA Vaccines and mRNA Drugs Production Market Share 2022
Figure 32. World mRNA Vaccines and mRNA Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World mRNA Vaccines and mRNA Drugs Production Value Market Share by Type in 2022
Figure 34. Vaccine
Figure 35. API
Figure 36. World mRNA Vaccines and mRNA Drugs Production Market Share by Type (2018-2029)
Figure 37. World mRNA Vaccines and mRNA Drugs Production Value Market Share by Type (2018-2029)
Figure 38. World mRNA Vaccines and mRNA Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World mRNA Vaccines and mRNA Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World mRNA Vaccines and mRNA Drugs Production Value Market Share by Application in 2022
Figure 41. Infectious Disease
Figure 42. Cancer
Figure 43. World mRNA Vaccines and mRNA Drugs Production Market Share by Application (2018-2029)
Figure 44. World mRNA Vaccines and mRNA Drugs Production Value Market Share by Application (2018-2029)
Figure 45. World mRNA Vaccines and mRNA Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. mRNA Vaccines and mRNA Drugs Industry Chain
Figure 47. mRNA Vaccines and mRNA Drugs Procurement Model
Figure 48. mRNA Vaccines and mRNA Drugs Sales Model
Figure 49. mRNA Vaccines and mRNA Drugs Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
Table 1. World mRNA Vaccines and mRNA Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World mRNA Vaccines and mRNA Drugs Production Value by Region (2018-2023) & (USD Million)
Table 3. World mRNA Vaccines and mRNA Drugs Production Value by Region (2024-2029) & (USD Million)
Table 4. World mRNA Vaccines and mRNA Drugs Production Value Market Share by Region (2018-2023)
Table 5. World mRNA Vaccines and mRNA Drugs Production Value Market Share by Region (2024-2029)
Table 6. World mRNA Vaccines and mRNA Drugs Production by Region (2018-2023) & (K Units)
Table 7. World mRNA Vaccines and mRNA Drugs Production by Region (2024-2029) & (K Units)
Table 8. World mRNA Vaccines and mRNA Drugs Production Market Share by Region (2018-2023)
Table 9. World mRNA Vaccines and mRNA Drugs Production Market Share by Region (2024-2029)
Table 10. World mRNA Vaccines and mRNA Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World mRNA Vaccines and mRNA Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 12. mRNA Vaccines and mRNA Drugs Major Market Trends
Table 13. World mRNA Vaccines and mRNA Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World mRNA Vaccines and mRNA Drugs Consumption by Region (2018-2023) & (K Units)
Table 15. World mRNA Vaccines and mRNA Drugs Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World mRNA Vaccines and mRNA Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key mRNA Vaccines and mRNA Drugs Producers in 2022
Table 18. World mRNA Vaccines and mRNA Drugs Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key mRNA Vaccines and mRNA Drugs Producers in 2022
Table 20. World mRNA Vaccines and mRNA Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global mRNA Vaccines and mRNA Drugs Company Evaluation Quadrant
Table 22. World mRNA Vaccines and mRNA Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and mRNA Vaccines and mRNA Drugs Production Site of Key Manufacturer
Table 24. mRNA Vaccines and mRNA Drugs Market: Company Product Type Footprint
Table 25. mRNA Vaccines and mRNA Drugs Market: Company Product Application Footprint
Table 26. mRNA Vaccines and mRNA Drugs Competitive Factors
Table 27. mRNA Vaccines and mRNA Drugs New Entrant and Capacity Expansion Plans
Table 28. mRNA Vaccines and mRNA Drugs Mergers & Acquisitions Activity
Table 29. United States VS China mRNA Vaccines and mRNA Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China mRNA Vaccines and mRNA Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China mRNA Vaccines and mRNA Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based mRNA Vaccines and mRNA Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers mRNA Vaccines and mRNA Drugs Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers mRNA Vaccines and mRNA Drugs Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers mRNA Vaccines and mRNA Drugs Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers mRNA Vaccines and mRNA Drugs Production Market Share (2018-2023)
Table 37. China Based mRNA Vaccines and mRNA Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers mRNA Vaccines and mRNA Drugs Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers mRNA Vaccines and mRNA Drugs Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers mRNA Vaccines and mRNA Drugs Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers mRNA Vaccines and mRNA Drugs Production Market Share (2018-2023)
Table 42. Rest of World Based mRNA Vaccines and mRNA Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers mRNA Vaccines and mRNA Drugs Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers mRNA Vaccines and mRNA Drugs Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers mRNA Vaccines and mRNA Drugs Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers mRNA Vaccines and mRNA Drugs Production Market Share (2018-2023)
Table 47. World mRNA Vaccines and mRNA Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World mRNA Vaccines and mRNA Drugs Production by Type (2018-2023) & (K Units)
Table 49. World mRNA Vaccines and mRNA Drugs Production by Type (2024-2029) & (K Units)
Table 50. World mRNA Vaccines and mRNA Drugs Production Value by Type (2018-2023) & (USD Million)
Table 51. World mRNA Vaccines and mRNA Drugs Production Value by Type (2024-2029) & (USD Million)
Table 52. World mRNA Vaccines and mRNA Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World mRNA Vaccines and mRNA Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World mRNA Vaccines and mRNA Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World mRNA Vaccines and mRNA Drugs Production by Application (2018-2023) & (K Units)
Table 56. World mRNA Vaccines and mRNA Drugs Production by Application (2024-2029) & (K Units)
Table 57. World mRNA Vaccines and mRNA Drugs Production Value by Application (2018-2023) & (USD Million)
Table 58. World mRNA Vaccines and mRNA Drugs Production Value by Application (2024-2029) & (USD Million)
Table 59. World mRNA Vaccines and mRNA Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World mRNA Vaccines and mRNA Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table 62. Thermo Fisher Major Business
Table 63. Thermo Fisher mRNA Vaccines and mRNA Drugs Product and Services
Table 64. Thermo Fisher mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Thermo Fisher Recent Developments/Updates
Table 66. Thermo Fisher Competitive Strengths & Weaknesses
Table 67. Merck Basic Information, Manufacturing Base and Competitors
Table 68. Merck Major Business
Table 69. Merck mRNA Vaccines and mRNA Drugs Product and Services
Table 70. Merck mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Merck Recent Developments/Updates
Table 72. Merck Competitive Strengths & Weaknesses
Table 73. Qiagen N.V. Basic Information, Manufacturing Base and Competitors
Table 74. Qiagen N.V. Major Business
Table 75. Qiagen N.V. mRNA Vaccines and mRNA Drugs Product and Services
Table 76. Qiagen N.V. mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Qiagen N.V. Recent Developments/Updates
Table 78. Qiagen N.V. Competitive Strengths & Weaknesses
Table 79. CureVac Basic Information, Manufacturing Base and Competitors
Table 80. CureVac Major Business
Table 81. CureVac mRNA Vaccines and mRNA Drugs Product and Services
Table 82. CureVac mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. CureVac Recent Developments/Updates
Table 84. CureVac Competitive Strengths & Weaknesses
Table 85. In-Cell-Art Basic Information, Manufacturing Base and Competitors
Table 86. In-Cell-Art Major Business
Table 87. In-Cell-Art mRNA Vaccines and mRNA Drugs Product and Services
Table 88. In-Cell-Art mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. In-Cell-Art Recent Developments/Updates
Table 90. In-Cell-Art Competitive Strengths & Weaknesses
Table 91. eTheRNA Basic Information, Manufacturing Base and Competitors
Table 92. eTheRNA Major Business
Table 93. eTheRNA mRNA Vaccines and mRNA Drugs Product and Services
Table 94. eTheRNA mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. eTheRNA Recent Developments/Updates
Table 96. eTheRNA Competitive Strengths & Weaknesses
Table 97. Takara Bio Inc. Basic Information, Manufacturing Base and Competitors
Table 98. Takara Bio Inc. Major Business
Table 99. Takara Bio Inc. mRNA Vaccines and mRNA Drugs Product and Services
Table 100. Takara Bio Inc. mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Takara Bio Inc. Recent Developments/Updates
Table 102. Takara Bio Inc. Competitive Strengths & Weaknesses
Table 103. Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors
Table 104. Sangamo Therapeutics Major Business
Table 105. Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Product and Services
Table 106. Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Sangamo Therapeutics Recent Developments/Updates
Table 108. Sangamo Therapeutics Competitive Strengths & Weaknesses
Table 109. Roche CustomBiotech Basic Information, Manufacturing Base and Competitors
Table 110. Roche CustomBiotech Major Business
Table 111. Roche CustomBiotech mRNA Vaccines and mRNA Drugs Product and Services
Table 112. Roche CustomBiotech mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Roche CustomBiotech Recent Developments/Updates
Table 114. Roche CustomBiotech Competitive Strengths & Weaknesses
Table 115. BioNTech Basic Information, Manufacturing Base and Competitors
Table 116. BioNTech Major Business
Table 117. BioNTech mRNA Vaccines and mRNA Drugs Product and Services
Table 118. BioNTech mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. BioNTech Recent Developments/Updates
Table 120. BioNTech Competitive Strengths & Weaknesses
Table 121. Tiba Biotechnology Basic Information, Manufacturing Base and Competitors
Table 122. Tiba Biotechnology Major Business
Table 123. Tiba Biotechnology mRNA Vaccines and mRNA Drugs Product and Services
Table 124. Tiba Biotechnology mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Tiba Biotechnology Recent Developments/Updates
Table 126. Tiba Biotechnology Competitive Strengths & Weaknesses
Table 127. TriLink Bio Technologies Basic Information, Manufacturing Base and Competitors
Table 128. TriLink Bio Technologies Major Business
Table 129. TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Product and Services
Table 130. TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. TriLink Bio Technologies Recent Developments/Updates
Table 132. TriLink Bio Technologies Competitive Strengths & Weaknesses
Table 133. Argos Therapeutics Basic Information, Manufacturing Base and Competitors
Table 134. Argos Therapeutics Major Business
Table 135. Argos Therapeutics mRNA Vaccines and mRNA Drugs Product and Services
Table 136. Argos Therapeutics mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Argos Therapeutics Recent Developments/Updates
Table 138. Argos Therapeutics Competitive Strengths & Weaknesses
Table 139. Moderna Therapeutics Basic Information, Manufacturing Base and Competitors
Table 140. Moderna Therapeutics Major Business
Table 141. Moderna Therapeutics mRNA Vaccines and mRNA Drugs Product and Services
Table 142. Moderna Therapeutics mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Moderna Therapeutics Recent Developments/Updates
Table 144. Moderna Therapeutics Competitive Strengths & Weaknesses
Table 145. NEB Basic Information, Manufacturing Base and Competitors
Table 146. NEB Major Business
Table 147. NEB mRNA Vaccines and mRNA Drugs Product and Services
Table 148. NEB mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. NEB Recent Developments/Updates
Table 150. NEB Competitive Strengths & Weaknesses
Table 151. Ethris Basic Information, Manufacturing Base and Competitors
Table 152. Ethris Major Business
Table 153. Ethris mRNA Vaccines and mRNA Drugs Product and Services
Table 154. Ethris mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Ethris Recent Developments/Updates
Table 156. Ethris Competitive Strengths & Weaknesses
Table 157. Aldevron Basic Information, Manufacturing Base and Competitors
Table 158. Aldevron Major Business
Table 159. Aldevron mRNA Vaccines and mRNA Drugs Product and Services
Table 160. Aldevron mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Aldevron Recent Developments/Updates
Table 162. Aldevron Competitive Strengths & Weaknesses
Table 163. Promega Basic Information, Manufacturing Base and Competitors
Table 164. Promega Major Business
Table 165. Promega mRNA Vaccines and mRNA Drugs Product and Services
Table 166. Promega mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Promega Recent Developments/Updates
Table 168. Translate Bio Basic Information, Manufacturing Base and Competitors
Table 169. Translate Bio Major Business
Table 170. Translate Bio mRNA Vaccines and mRNA Drugs Product and Services
Table 171. Translate Bio mRNA Vaccines and mRNA Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 172. Global Key Players of mRNA Vaccines and mRNA Drugs Upstream (Raw Materials)
Table 173. mRNA Vaccines and mRNA Drugs Typical Customers
Table 174. mRNA Vaccines and mRNA Drugs Typical Distributors
List of Figure
Figure 1. mRNA Vaccines and mRNA Drugs Picture
Figure 2. World mRNA Vaccines and mRNA Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World mRNA Vaccines and mRNA Drugs Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World mRNA Vaccines and mRNA Drugs Production (2018-2029) & (K Units)
Figure 5. World mRNA Vaccines and mRNA Drugs Average Price (2018-2029) & (US$/Unit)
Figure 6. World mRNA Vaccines and mRNA Drugs Production Value Market Share by Region (2018-2029)
Figure 7. World mRNA Vaccines and mRNA Drugs Production Market Share by Region (2018-2029)
Figure 8. North America mRNA Vaccines and mRNA Drugs Production (2018-2029) & (K Units)
Figure 9. Europe mRNA Vaccines and mRNA Drugs Production (2018-2029) & (K Units)
Figure 10. China mRNA Vaccines and mRNA Drugs Production (2018-2029) & (K Units)
Figure 11. Japan mRNA Vaccines and mRNA Drugs Production (2018-2029) & (K Units)
Figure 12. mRNA Vaccines and mRNA Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World mRNA Vaccines and mRNA Drugs Consumption (2018-2029) & (K Units)
Figure 15. World mRNA Vaccines and mRNA Drugs Consumption Market Share by Region (2018-2029)
Figure 16. United States mRNA Vaccines and mRNA Drugs Consumption (2018-2029) & (K Units)
Figure 17. China mRNA Vaccines and mRNA Drugs Consumption (2018-2029) & (K Units)
Figure 18. Europe mRNA Vaccines and mRNA Drugs Consumption (2018-2029) & (K Units)
Figure 19. Japan mRNA Vaccines and mRNA Drugs Consumption (2018-2029) & (K Units)
Figure 20. South Korea mRNA Vaccines and mRNA Drugs Consumption (2018-2029) & (K Units)
Figure 21. ASEAN mRNA Vaccines and mRNA Drugs Consumption (2018-2029) & (K Units)
Figure 22. India mRNA Vaccines and mRNA Drugs Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of mRNA Vaccines and mRNA Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for mRNA Vaccines and mRNA Drugs Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for mRNA Vaccines and mRNA Drugs Markets in 2022
Figure 26. United States VS China: mRNA Vaccines and mRNA Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: mRNA Vaccines and mRNA Drugs Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: mRNA Vaccines and mRNA Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers mRNA Vaccines and mRNA Drugs Production Market Share 2022
Figure 30. China Based Manufacturers mRNA Vaccines and mRNA Drugs Production Market Share 2022
Figure 31. Rest of World Based Manufacturers mRNA Vaccines and mRNA Drugs Production Market Share 2022
Figure 32. World mRNA Vaccines and mRNA Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World mRNA Vaccines and mRNA Drugs Production Value Market Share by Type in 2022
Figure 34. Vaccine
Figure 35. API
Figure 36. World mRNA Vaccines and mRNA Drugs Production Market Share by Type (2018-2029)
Figure 37. World mRNA Vaccines and mRNA Drugs Production Value Market Share by Type (2018-2029)
Figure 38. World mRNA Vaccines and mRNA Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World mRNA Vaccines and mRNA Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World mRNA Vaccines and mRNA Drugs Production Value Market Share by Application in 2022
Figure 41. Infectious Disease
Figure 42. Cancer
Figure 43. World mRNA Vaccines and mRNA Drugs Production Market Share by Application (2018-2029)
Figure 44. World mRNA Vaccines and mRNA Drugs Production Value Market Share by Application (2018-2029)
Figure 45. World mRNA Vaccines and mRNA Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. mRNA Vaccines and mRNA Drugs Industry Chain
Figure 47. mRNA Vaccines and mRNA Drugs Procurement Model
Figure 48. mRNA Vaccines and mRNA Drugs Sales Model
Figure 49. mRNA Vaccines and mRNA Drugs Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
